Glucagon-Like Peptide-1 Receptor Agonist and Sodium-Glucose Cotransporter 2 Inhibitor Prescriptions in Type 2 Diabetes by Kidney and Cardiovascular Disease

J Am Soc Nephrol. 2024 Nov 27. doi: 10.1681/ASN.0000000585. Online ahead of print.

Sneha S Mehta¹, Aditya L Surapaneni¹, Krutika Pandit¹, Yunwen Xu², Leora Horwitz^{1

3}, Saul Blecker^{1

3}, Matthew F Blum⁴, Alexander R Chang⁵, Jung-Im Shin², Morgan E Grams^{1

2

6}

¹ Department of Medicine, NYU Grossman School of Medicine, New York, New York.
² Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
³ Center for Healthcare Innovation and Delivery Science, NYU Langone Health, Departments of Population Health and Medicine, NYU Grossman School of Medicine, New York, New York.
⁴ Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.
⁵ Departments of Nephrology and Population Health Sciences, Geisinger Health, Danville, Pennsylvania.
⁶ Departments of Medicine and Population Health NYU Grossman School of Medicine, New York, New York.

No abstract available

Grants and funding